1. Pink Sheet

'We Are Not Waiting To Be Replaced': Medical Affairs Pros Take On GPT-4o

 
• By Brian Yang

Faster, more powerful and able to handle voices and visual images, newly released AI platform GPT-4o could potentially accelerate many tasks currently handled by pharma firms' medical affairs professionals, who are exploring ways to keep themselves relevant while embracing the unprecedented technology, DIA China hears.

Generative AI ChatGPT
Medical affairs pros are already taking on GPT-4o, speakers at DIA China say • Source: Shutterstock

Boehringer Ingelheim GmbH is one of many pharma companies experimenting with new ways to leverage artificial intelligence (AI) to innovate their ways of distributing information and communicating with patients.

Key Takeaways:

  • Powerful new AI tool GPT-4o is stirring up fears that it could replace medical affairs and writing professionals.

A frontrunner among such firms looking to adopt AI, augmented reality and new digital media tools, it has already identified...

Read the full article – start your free trial today!

Join thousands of industry professionals who rely on Pink Sheet for daily insights

  • Start your 7-day free trial
  • Explore trusted news, analysis, and insights
  • Access comprehensive global coverage
  • Enjoy instant access – no credit card required
Start Free Trial

Already a subscriber?

More from AI

More from Advanced Technologies